Evidence map›Paper›PMID 22609512›Full record

ArticleJournal of proteomics2012

Novel tyrosine phosphorylation sites in rat skeletal muscle revealed by phosphopeptide enrichment and HPLC-ESI-MS/MS.

Xiangmin Zhang, Kurt Højlund, Moulun Luo, Christian Meyer, Thangiah Geetha, Zhengping Yi

Open access · greenAbstract read
In one paragraph

Article in Journal of proteomics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Xiangmin ZhangDepartment of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy & Health Sciences, Wayne State University, Detroit, MI, USA.
Kurt Højlund
Moulun Luo
Christian Meyer
Thangiah Geetha
Zhengping Yi
Arizona State University · USAuburn University · USEugene Applebaum College of Pharmacy and Health Sciences · USOdense University Hospital · DK

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Human Skeletal Muscle Proteome and Phosphoproteome in Obesity and Type 2 DiabetesR01DK081750 · NIDDK · WAYNE STATE UNIVERSITY · PI YI, ZHENGPING · 2009 to 2017
$3.0M
Adipocyte Mithochondrial Dysfunction in Insulin ResistanceR21DK082820 · NIDDK · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI MEYER, CHRISTIAN · 2009 to 2010
$404k
NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK081750NIDDK NIH HHS R01DK081750NIDDK NIH HHS R21 DK082820NIDDK NIH HHS R21DK082820
6 · The paper itself

Abstract

Tyrosine phosphorylation plays a fundamental role in many cellular processes including differentiation, growth and insulin signaling. In insulin resistant muscle, aberrant tyrosine phosphorylation of several proteins has been detected. However, due to the low abundance of tyrosine phosphorylation (<1% of total protein phosphorylation), only a few tyrosine phosphorylation sites have been identified in mammalian skeletal muscle to date. Here, we used immunoprecipitation of phosphotyrosine peptides prior to HPLC-ESI-MS/MS analysis to improve the discovery of tyrosine phosphorylation in relatively small skeletal muscle biopsies from rats. This resulted in the identification of 87 distinctly localized tyrosine phosphorylation sites in 46 muscle proteins. Among them, 31 appear to be novel. The tyrosine phosphorylated proteins included major enzymes in the glycolytic pathway and glycogen metabolism, sarcomeric proteins, and proteins involved in Ca(2+) homeostasis and phosphocreatine resynthesis. Among proteins regulated by insulin, we found tyrosine phosphorylation sites in glycogen synthase, and two of its inhibitors, GSK-3α and DYRK1A. Moreover, tyrosine phosphorylation sites were identified in several MAP kinases and a protein tyrosine phosphatase, SHPTP2. These results provide the largest catalogue of mammalian skeletal muscle tyrosine phosphorylation sites to date and provide novel targets for the investigation of human skeletal muscle phosphoproteins in various disease states.

Indexed as

AnimalsChromatography, High Pressure LiquidDyrk KinasesExtracellular Signal-Regulated MAP KinasesGlycogen Synthase Kinase 3HumansMaleMuscle ProteinsMuscle, SkeletalPhosphopeptidesPhosphoproteinsPhosphorylationProtein Serine-Threonine KinasesProtein-Tyrosine KinasesProtein Tyrosine Phosphatase, Non-Receptor Type 11RatsDyrk KinasesExtracellular Signal-Regulated MAP KinasesGlycogen Synthase Kinase 3glycogen synthase kinase 3 alphaMuscle ProteinsPhosphopeptidesPhosphoproteinsProtein Serine-Threonine KinasesProtein-Tyrosine KinasesProtein Tyrosine Phosphatase, Non-Receptor Type 11Tyrosine

Identifiers

PMID22609512
PMCPMC3398612
OpenAlexW2018197188

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.